Corcept Therapeutics
CORT
#1631
Rank
S$16.77 B
Marketcap
S$155.17
Share price
2.24%
Change (1 day)
61.82%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of June 2026 : S$12.06 Million

According to Corcept Therapeutics 's latest financial reports the company's total debt is S$12.06 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2026)

Total debt by year

Year Total debt Change
2025-12-31S$7.84 M-16.83%
2024-12-31S$9.42 M4627.52%
2023-12-31S$0.19 M-86.99%
2022-12-31S$1.53 M115.48%
2021-12-31S$0.71 M-78.93%
2020-12-31S$3.37 M-27.67%
2019-12-31S$4.66 M
2018-12-31N/A
2016-12-31S$21.22 M0.26%
2015-12-31S$21.16 M70%
2014-12-31S$12.45 M71.14%
2013-12-31S$7.27 M124.53%
2012-12-31S$3.24 M
2010-12-31N/A-100%
2009-12-31S$0 M-63.19%
2008-12-31S$0.02 M-45.17%
2007-12-31S$0.04 M-35.2%
2006-12-31S$0.06 M-28.37%
2005-12-31S$0.08 M
2003-12-31S$0.88 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
S$62.78 B 520,396.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$62.75 B 520,163.24%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$80.91 B 670,678.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$70.30 B 582,725.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$69.02 B 572,089.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$57.68 B 478,118.87%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
S$0.42 B 3,411.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.32 B 2,581.54%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$5.38 B 44,504.61%๐Ÿ‡บ๐Ÿ‡ธ USA